NCT04110028View on ClinicalTrials.gov

Nicotinamide Riboside in Hospitalized Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2023

Conditions
InflammationAcute Illness
Interventions
DRUG

Nicotinamide riboside

Nicotinamide riboside in different doses

DRUG

Placebo

Placebo

Trial Locations (1)

0450

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

ChromaDex, Inc.

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT04110028 - Nicotinamide Riboside in Hospitalized Patients | Biotech Hunter | Biotech Hunter